Alyson Wooten focuses her practice on patent litigation with emphasis in the area of health and life sciences. Registered as a patent attorney and pharmacist, Dr. Wooten has broad experience in the pharmaceutical industry, including medical services, regulatory, marketing and clinical trial analysis. Dr. Wooten has represented several big medical and research facilities in a number of federal courts. She has participated in all aspects of patent litigation, including invalidity and infringement investigations, claim construction, preparation of expert reports and settlement negotiations. While attending law school, Dr. Wooten worked as a patent agent for a leading pharmaceutical company focusing on patent prosecution for new chemical entities and Paragraph IV litigation. Dr. Wooten was recognized in 2011 as a Georgia "Rising Star" in the area of Intellectual Property Litigation by SuperLawyers magazine. Professional & Community Activities American Bar Association, Member American International Property Law Association, Member Metropolitan Counseling Services, Board of Directors Temple University Law School, Student Bar Association, Past Class Division Vice President Industries Health & Life Sciences Experience Worked on teams handling the following matters: Smith & Nephew Inc. v. Synthes (U.S.A.), Represented Smith & Nephew in a patent infringement suit against Synthes Corp. in the Western District of Tennessee. After a three-week bench trial, the court found Smith & Nephew's patents to be valid and infringed. The court entered a permanent injunction in September 2006 enjoining Synthes from continuing to sell infringing bone repair devices. This is one the first permanent injunctions entered in a patent case after the Supreme Court's eBay opinion. After briefing and argument in the Federal Circuit, the parties reached a confidential settlement of the case.
Smith & Nephew Inc. v. Synthes (U.S.A.), 466 F. Supp.2d 978 (W.D. Tenn. 2006). Grandparent adoption, Represents caregivers seeking to adopt children. One of the firm's signature pro bono programs is the Grandparent Adoption Program. Dozens of lawyers have been trained to represent grandparents and other relative caregivers who step up to raise young children in their extended family when the children's parents are unable or unwilling to do so. Working in partnership with local legal aid programs, lawyers accept referrals of eligible families, and prepare and file the required documents to effect the adoption. Hundreds of children's lives have been stabilized as a result of the firm's involvement. Patent counseling services for leading pharmaceuticals manufacturer, Provided patent counseling services including patent license review, dispute resolution and pre-litigation counseling to leading pharmaceuticals manufacturer related to reexamination and reissue applications for large and small molecule therapeutics. Biopolymer Engineering Inc. v. Immunocorp, The firm served as lead counsel for Biotec Pharmacon, ASA, a Norwegian pharmaceutical company, in patent infringement litigation initiated by patent owner Biothera, a Minnesota corporation, in the District of Minnesota in Minneapolis. The 14 patents involved in the litigation relate to, among other things, beta glucan compositions for immunotherapy. The District Court granted summary judgment of non-infringement as to 12 of the 14 patents, and the case subsequently settled.
Biopolymer Eng'g, Inc. v. Immunocorp, No. 05-00536 (D. Minn. filed Mar. 14, 2005). Oklahoma Med. Research Found. v. Alexion Pharmaceuticals Inc., The firm served as lead counsel on behalf of Oklahoma Medical Research Foundation in a patent infringement suit brought in the Northern District of Oklahoma against Alexion Pharmaceuticals. The patents related to complement-inhibition technology and their use in a drug marketed by Alexion to treat a rare, debilitating and life-threatening disease. After replacing OMRF's previous counsel in the matter and soon after claim construction briefing was complete, we obtained a settlement. It included payment to our client as well as public acknowledgement that individuals affiliated with OMRF were the true inventors of the technology at issue.
Oklahoma Med. Research Found. v. Alexion Pharmaceuticals, Inc., No. 07-163 (N.D. Okla. filed Mar. 15, 2007). *Experience gained by attorney prior to joining Kilpatrick Townsend Publications 24 March 2010, Separate Written Description - En Banc Decision in Ariad v. Lilly, Legal Alerts 08 December 2009, Separate Written Description? - Oral Arguments In En Banc Rehearing of Ariad v. Lilly, Legal Alerts 01 May 2009, Protecting the Validity of Your Pharmaceutical Patents After KSR
Source: 2009 BIO International Convention, Articles 07 April 2009, In re Kubin - Another Hurdle for DNA Sequence Patents, Legal Alerts 01 January 2009, Patent Law Basics: An Overview of Patent Law and Avoiding the Loss of Rights
Source: Intellectual Property Desk Reference, Other Publications News 02 March 2011, Kilpatrick Townsend Once Again Achieves Top Recognition in 2011 Georgia Super Lawyers, News Releases |